Y. Rajesh

Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo

Aditya Parekh, Subhayan Das, Sheetal Parida et al. · Oncogene · 2018 · 101 citations

Medicine, Cancer Biology, Oncology +13

Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis)

Bhesh Raj Sharma, Rajendra Karki, Y. Rajesh et al. · Journal of Biological Chemistry · 2023 · 101 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy

Sheetal Parida, Chiranjit Maiti, Y. Rajesh et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2016 · 67 citations

Pharmacy, Oncology, Pharmaceutics +17

Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma

Y. Rajesh, Angana Biswas, Utkarsh Kumar et al. · Biochemical Pharmacology · 2019 · 55 citations

Medicine, Oncology, Pharmacology +16

Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma

Y. Rajesh, Angana Biswas, Utkarsh Kumar et al. · Proceedings of the National Academy of Sciences · 2020 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17